Division of Codman Neuro/Micrus Endovascular Corp.
Latest From Neuro
Brief summaries of recent clinical developments in the device industry, including cell therapy for arrhythmias, hospitalization for young diabetics, cooling to save trauma patients, cell regeneration in the intestine, and lack of efficacy for popular osteoarthritis treatments.
Brief summaries of recent product and company developments in the device industry, including: developments in continuous glucose monitoring, new liability conerns for device companies, medtech acquisitions in 2007, and the 2008 IPO market.
Patient safety dominated the discussions at the 2007 annual meeting of the American Society of Anesthesiologists. Although medtech manufacturers have long focused on improving safety, that movement is being further fueled by a growing number of performance measures and documentation requirements. In addition, pay-for-performance initiatives are gaining in popularity as health care buyers seek ways to drive quality improvements, putting more pressure on hospitals and physicians to provide and document quality care in order to maximize their reimbursements.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.